Access links:
CONTENT
Destacados
1st Symposium Tuberculosis Watch. Can we eradicate TB?
27.09.12 - 27.09.12
Link del congréshttp://www.uoc.edu/symposia/symposium_tb_watch2012/presentacio_eng.html
Promoted by the Health Sciences Department of the Universitat Oberta de Catalunya (Open University of Catalonia, UOC) and Dr. Pere-Joan Cardona, a renowned expert in research into tuberculosis (TB), the international symposium "Can we eradicate TB?" is being organised to coincide with the creation of the University's new specialisation in Clinical TB Management.
The idea is for the specialisation and the symposium to generate synergies and complement one another, with the ultimate goal of taking an essentially practical approach to furthering knowledge of TB and improving the way the disease is dealt with at all levels. The symposium, which is being held for the first time, will boast a number of international speakers, all chosen for the event on the basis of their experience and knowledge in their respective areas of expertise.
The presence of leading figures from the TB is bound to attract an international audience to the event. They will undoubtedly provide food for thought for attendees, guaranteeing a modern symposium with a wealth of opinions and a major post-event impact. Contrary to popular belief, TB is by no means close to being eradicated, basically due to certain shortcomings hindering progress where research, diagnosis and treatment are concerned. Constant dialogue and interaction between the various parties involved in the different aspects of tackling the disease are vital to optimising the practical effect generated.
In relation to its target audience, the symposium aims to bridge a gap that currently exists, particularly in Spain, with a view to training medical workers to deal with TB and placing the latest research at their disposal to make them fully aware of the real context of the situation. The symposium is set to be a platform for nurturing future international cooperation. It will contribute to the extension of the network via which knowledge and details of opportunities abroad are disseminated, to the development of common strategies for progress in research and seeking European funding, and to the implementation of general action plans related to diagnosis and/or treatment.
More information:
